[The drug prevention of postoperative thromboses in patients with critical lower limb ischemia].
Based on the author's findings a conclusion has been reached that it is expedient to use fraxiparin, a low-molecular heparin, in the early postoperative period after reconstructive operations on the arteries, and ticlid, a deaggregant on a regular basis, in the remote postoperative period, this drug having been found to increase the percentage of spared critically ischemized limbs compared with aspirin.
Kobza
I I
II
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D016638:Critical Illness; D006801:Humans; D007511:Ischemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D017762:Nadroparin / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011182:Postoperative Care; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control*; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control*; D013988:Ticlopidine / Q000627:therapeutic use; D013997:Time Factors; D014656:Vascular Surgical Procedures
D000925:Anticoagulants; D017762:Nadroparin; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin